← FDA DRUG APPROVALS

FDA ANDA · ANDA077236

PREDNICARBATE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA077236
TYPE
ANDA
ORIGINAL APPROVAL
2007-03-09
LATEST ACTION
2015-09-25
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

PREDNICARBATEPrescription
PREDNICARBATE 0.1% · OINTMENT · TOPICAL

Approval history

2015-09-25Labeling · Supplement 1 · standardAP
2007-03-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →